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Following the recent explosion in the number of
designs for short-term assays for mutagens and car-
cinogens it appears worthwhile to take stock of the
current situation and speculate about future de-
velopments. Over 400 strong, weak, and noncar-
cinogenic compounds have been examined by one
or the other of the microbial tests, Drosophila
assay, or the DNA fragmentation/DNA repair
system of cultured mammalian cells. Between 80
and 90o of examined carcinogens give a positive
response if checked with one test. If the results of
several tests are pooled, only a very few carcino-
gens escape detection. In spite of these highly
promising results, there is a reluctance on the part
ofregulatory agencies to accept wholeheartedly the
rapid, inexpensive, and reproducible short-term
bioassays. Why? The phylogenetic relationship
between bacteria and man appears for some too re-
mote to permitan extrapolation from microbial tests
to human populations. Others doubt the validity of
using point mutations as an endpoint, claiming that
mutations may not play a role in neoplastic trans-
formation and thus cannot be used as a relevant
endpoint.
One answer to these heretics could be to rank the
various endpoints including, of course, car-
cinogenicity and to calculate a coefficient of rank
correlation. Another answer would be to use sev-
eral well chosen, short-term assays which comple-
ment each other. The Salmonella mutagenicity test
in combination with activation systems (1) and the
recombination assay of Kada (2) can be applied to
mutagens/carcinogens found in the environment, in
complex mixtures, or in body fluids of man. DNA
fragmentation/DNA repair assays on cultured
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human cells (3) can be used to simulate conditions
prevailing in man, and should, therefore, produce
data of high relevance to human populations (4).
DNA fragmentation in various organs of mice or
rats fed the carcinogenic compounds (5) appears to
incorporate the convenience of in vitro assays with
the completeness of the metabolic activation/
deactivation system of the whole animal.
In this short report we would like to point to sev-
eral advantageous features ofusing cultured human
cells as indicators and DNA fragmentation/DNA
repair as endpoints. The outstanding advantage of
this test system is its adaptability to situations
which prevail in man, thus permitting an easy
transfer of in vitro results to in vivo conditions. A
few examples should illustrate this point.
Carcinogenic nitrosation products can be readily
detected when nitrosation is carried out in simu-
lated gastric juice (6). Genetically controlled sus-
ceptibility can be uncovered by estimating the level
of repair synthesis following various chemical car-
cinogens (7) or the reactivation of ultraviolet-
irradiated DNA viruses (8, 9). If these techniques
are combined with cell survival studies, variations
in sensitivity within human population groups
could be detected.
The susceptibility ofhuman cells to chemical car-
cinogens can be enhanced by interfering with their
DNA repair capacity. The effect of ascorbic acid
on DNA repair synthesis and cell survival follow-
ing exposure to the potent carcinogen 4NQO
exemplifies this pattern (10).
Most screening procedures are based on response
to single doses. However, the average man in an
industrial society is repeatedly exposed to various
carcinogens. A preliminary study on the effect of
two consecutive doses revealed a "refractive
period" following the application of a carcinogenic
February 1978 131agent (UV, 4NQO or MNNG). During this period,
the cell cannot respond to a second dose with a
normal level ofDNA repair synthesis. In this stage
the cell temporarily acquires an elevated sensitivity
to the chromosome damaging action and lethal ef-
fect of chemical mutagens/carcinogens (11).
The interaction ofchemical and physical agents is
another area which has received less attention than
it merits, e.g., the combined use of psoralen and
long ultraviolet-radiation in the treatment of
psoriasis. DNA fragmentation and DNA repair of
epidermal cells can be employed to assess the po-
tential hazard of this therapy to the genome of
somatic cells. To what extent photosensitizing
chemicals (12) enter man and sensitize him to the
action of radiation is difficult to assess at present.
The use of human cells also offers the opportu-
nity to study the effect of human viruses on the
response of cells toward chemical carcinogens. All
the variations found in nature can be easily simu-
lated in the tissue culture systems. Cells with an
infectious virus replicative cycle or with abortive
infection, cells with a latent virus, and cells with an
integrated viral genome can be exposed to chemical
carcinogens and their response compared to that of
noninfected cells. A profound understanding ofthe
virus-chemical carcinogen interactions should
greatly improve the predictive value of short-term
assays.
Finally, the complex interplay between chemical
carcinogens, viruses and genetic composition ofthe
target cells must be unravelled to understand the
factors which enhance or reduce the risk of neo-
plastic transformation (13).
In spite of the many advantages offered by the
above-mentioned bioassays, there are several unre-
solved issues that need attention. For the sake of
simplicity we have used fibroblasts obtained from
small skin biopsies of normal and genetically-
afflicted persons of high cancer risk. Thus all our
studies are done on fibroblasts instead of the epi-
dermal cells from which most human tumors arise.
Criticism can also be directed toward the exclusive
use ofcultured cells forced to grow on glass or plas-
tic surfaces. The possibility of whether human
organ pieces could be grown in immunodepressed
mice which are then exposed to chemical carcino-
gens should be explored. This approach, if suc-
cessful, would have the advantage ofhaving human
target tissue in its original form treated with chemi-
cal carcinogens.
In our opinion there is at present little to gain in
the continuous introduction of new short term as-
says or new indicator subjects. We would rather
favor the selection ofa very few bioassays and pro-
ceed with their in depth analysis. Serious con-
sideration should be given to: (I) bioassays which
are the most rapid, economic and reproducible for
the large-scale screening of carcinogens in man's
environment and (2) bioassays which can simulate
closest the conditions prevailing in man. The com-
binationofboth groups ofbioassays should increase
their predictive value in assessing carcinogenic
hazards to human populations, and should find
acceptance by regulatory agencies.
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